Presidents

  • Dino Amadori
  • Rosella Silvestrini

Scientific Committee

  • Giovanni Luca Frassineti
  • Giorgio Cruciani
  • Ugo De Giorgi
  • Muller Fabbri
  • Pier Paolo Fattori
  • Giampaolo Gavelli
  • Toni Ibrahim
  • Carlo Milandri
  • Oriana Nanni
  • Giovanni Paganelli
  • Rolando Polico
  • Alberto Ravaioli
  • Ruggero Ridolfi
  • Andrea Rocca
  • Wainer Zoli

Organizing Committee

  • Carlo Milandri
  • Salvatore Luca Burgio
  • Alberto Farolfi
  • Andrea Casadei Gardini
  • Talia Piolanti
  • Marianna Ricci
  • Martina Valgiusti
  • Gráinne Tierney
  • Annalisa Volpi

Scientific Secretariat

Istituto Scientifico Romagnolo
per lo Studio e la cura dei Tumori
Via Maroncelli, 40
47014 Meldola (FC), Italy
Tel. +39.0543.739254-51
ufficio.formazione@irst.emr.it
irst.emr.it

Organizing Secretariat

Studio E.R. Congressi - Triumph Group
Via Marconi, 36
40122 Bologna, Italy
Tel. +39.051.4210559
Fax +39.051.4210174
ercongressi@triumphgroup.it
ercongressi.it

Presidents

  • Dino Amadori
    Scientific Director

    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
    Meldola
  • Rosella Silvestrini
    Scientific Adviser

    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
    Meldola

General information

Language

The Conference will be in English with no simultaneous translation into other languages.

Badge

All registered participants, speakers and exhibitors will be given a badge which they must wear to be admitted to the scientific sessions.

Attendance certificate

A certificate will be given to all participants at the end of the Conference.

Italian CME credits

Two requests for Italian CME credits have been made for physicians, biologists, technicians, pharmacists, nurses and physicists.
The Italian Ministry of Health allows:
5.5 CME credits for May 8-9, 2012
6 CME credits for May 10-11, 2012
At the registration desk attendees will receive two different evaluation forms related to each request.

ESMO-MORA points

The conference has been awarded the ESMO Label with: 8 ESMO-MORA cat. 1 points.

Registration Fees (inclusive of VAT)

ISO members Euro 100
AIOM membersEuro 100,00
ESMO membersEuro 100,00
ISO membersEuro 100,00
Participants under 35 yearsEuro 100,00
OthersEuro 200,00

The registration fees include: participation in the scientific sessions, access to exhibition area, attendance certificate, Conference proceedings dvd, lunches, coffee breaks and welcome cocktail.


How to register

The completed registration form (also available on line at Pdf registration) and payment must be sent by fax to: +39 051 4210174. Registration can only be accepted and confirmed when the registration form and payment have been received by the Organizing Secretariat Studio E.R. Congressi.

Meeting location

Meeting Venues

Hotel Globus City
Via Traiano Imperatore, 4
47122 Forlì, Italy
Tel. +39.0543.722215
hotelglobuscity.com

Istituto Scientifico Romagnolo
per lo Studio e la Cura dei Tumori
Via Maroncelli, 40
47014 Meldola (FC), Italy
Ph. +39 0543 739254 - 51
ufficio.formazione@irst.emr.it
www.irst.emr.it

How to reach the meeting venues

IRST - Meldola
A shuttle service from Hotel Globus City to Meldola and back will be provided according to the meeting timetable. Please contact the Organizing Secretariat for further information.
Hotel Globus City - Forlì
By plane: Bologna G. Marconi Airport, 70 km.
By car: A14 Bologna-Taranto Motorway, exit "Forlì", 500 m. Free parking.
By train: Forlì train station, 2 km.

Hotel and Travel Agency

BONONIA VIAGGI BT&I,
Piazza dei Martiri 1
40122 Bologna, Italy
Tel: +39 051 4211585 – Fax +39 051 249846
paola.libbra@bononiaviaggi.it

Download the pdf file, fill it and send it by fax.
Hotel pdf file

Program

Under the Auspices of:

  • Alto Patronato del Presidente della Repubblica Italiana
  • Ministero della Salute
  • Ministero dell'Istruzione, dell'Università e della Ricerca

  • Regione Emilia Romagna
  • Provincia Forlì-Cesena
  • Comune di Forlì

  • Ordine dei Medici e Odontoiatri Forlì-Cesena
  • Azienda Unità Sanitaria Locale di Forlì

  • AIOM, Associazione Italiana di Oncologia Medica
  • AIRO, Associazione Italiana di Radioterapia Oncologica
  • ESMO, European Society for Medical Oncology
  • FISM, Federazione delle Società Medico-Scientifiche Italiane
  • IOR, Istituto Oncologico Romagnolo
  • ISO, Società Italiana di Osteoncologia
  • LILT, Lega Italiana per la Lotta contro i Tumori
  • SIC, Società Italiana di Cancerologia
  • SIE, Società Italiana di Ematologia

Topics

The Conference objectives are to examine the link between research into cancer and clinical applications of laboratory findings, and to focus on the biomolecular development of new biological drugs. The event also aims to promote open dialogue between laboratory researchers, clinical oncologists and pharmaceutical companies, of fundamental importance for the successful translation of research into clinical practice. Areas of interest are as follows:

  1. Breast cancer
  2. Gastrointestinal cancer
  3. Onco-hematology
  4. Genitourinary cancer
  5. Lung cancer
  6. Melanoma
  7. Osteoncology
  1. Immunotherapy
  2. Microenvironment and tissue architecture
  3. miRNA
  4. Biobanking
  5. Circulating Tumor Cells
  6. Radiobiology
  7. Radionuclide Therapy

Call for abstract (poster session only)

We invite all investigators to submit abstracts to the Organizing Secretariat (c.fiorini@triumphgroup.it), the deadline for which is March 31, 2012.
Abstract must be in English: max. 250 words (excluding spaces). The word count does not include title, author names or affiliations).

Registration form

Download the pdf file, fill it and send it by fax.
Registration form

Contacts


Scientific Secretariat

Istituto Scientifico Romagnolo
per lo Studio e la Cura dei Tumori
Via Maroncelli, 40
47014 Meldola (FC), Italy
Tel. +39.0543.739254-51
ufficio.formazione@irst.emr.it

Organizing Secretariat

Studio E.R. Congressi - Triumph Group
Via Marconi, 36
40122 Bologna, Italy
Tel. +39.051.4210559
Fax +39.051.4210174
ercongressi@triumphgroup.it
ercongressi.it

Hotel and Travel agency

BONONIA VIAGGI BT&I,
Piazza dei Martiri 1
40122 Bologna, Italy
Tel: +39 051 4211585
Fax +39 051 249846
paola.libbra@bononiaviaggi.it

Posters

Session 1

P01

Fenretinide: new perspectives in treatment of medulloblastoma

P02

Isolation of living circulating tumor cells using the DEPArrayTM platform

P03

I.R.S.T.'s surveillance of therapeutic use of investigational medicinal product's under Italian Ministerial Decree 8 May 2003 (D.M. 08/05/2003): possible tool to generate translational research's hypothesis

P04

Investigation of circulating colon and lung cancer cells using dielectrophoresis-based instrumentation

P05

BRAF gene mutation and MLH1 promoter methylation in colorectal carcinomas with microsatellite instability and loss of MLH1 protein expression

P06

Developing of an in vitro model of breast cancer osteolytic bone metastasis for preclinical trials of novel bone-targeted molecules

P07

Phosphorylated Akt and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecancetuximab

P08

Highly sensitive FRET biosensors for detecting MT1-MMP activity in live breast cancer cells

P09

Molecular characterization of breast cancer cell lines after zoledronic acid treatment

P10

Mini-gene profiling for the prediction of metastatization to bone in breast cancer patients

P11

Osteoncology Center: the management of patients with bone cancer disease in a multidisciplinary approach

P12

MicroRNA profile in osteosarcoma: role of miR-1 and miR-133b

P13

Circulating RANK/RANK-L/OPG pathway in cancer patients treated with Zoledronic Acid

P14

The role of Research Nurse in the management of bone cancer patients in the multidisciplinary Osteoncology Center (CDO)

P15

Circulating tumour cells from bench to bed: streamlining from technological research to clinical practice

P16

EGFR and K-RAS analysis in cytological specimens from Non Small Cell Lung Cancer (NSCLC) patients

P17

Multiple marker detection in peripheral blood for NSCLC diagnosis

Session 2

P18

Slug silencing increases radiosensitivity of melanoma cells in vitro

P19

Cancer region detection by visual features in histopathology

P20

Extension of the microscope's depth of focus

P21

Assessing reliability in computation of perfusion CT indexes

P22

Detecting early errors in DCE-CT imaging

P23

Role of telomerase activity in predicting the clinical outcome of patients with benign lesions of the uterine cervix or CIN

P24

Feasibility study of translational research in Africa: preliminary data on the biology of 71 breast cancer cases from Bugando Medical Center

P25

Protective effect of Rosiglitazone on late pulmonary damage and radiation-induced acute intestinal damage on a murine model

P26

Prognostic value of proliferation marker Ki67 in advanced breast cancer

P27

Hormone receptor, Her-2 and Ki67 discordance between primary breast cancer and paired metastases: clinical impact

P28

Local antitumor immune responses in tumor tissues after vaccination with dendritic cell (DC) vaccine in patients with advanced melanoma

P29

The Abs.I.De. (Abscopal Effect, Interferon-alpha, Dendritic Cell Vaccine) study: a randomized phase II "Proof of Concept" clinical study in Advanced Melanoma

P30

Antitumor activity of Zoledronic Acid in combination with Cisplatin in triple negative breast cancer cell lines

P31

Specific biomarkers are associated to docetaxel and gemcitabine resistant NSCLC cell lines

P32

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with High-dose Interleukin-2 (HD-IL-2)

P33

The therapeutic activity of gemcitabine on transplanted intracranially Ehrlich tumor in mice